Cleopatra Hospital Co (CAI:CLHO) Enterprise Value: E£27,968 Mil (As of Jun. 28, 2026) ***


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
88 GF Score
Price E£16.10
GF Value E£13.82
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co Enterprise Value?

Cleopatra Hospital Co CAI:CLHO -4.17% 88 Enterprise Value is E£27,968 Mil as of Jun. 28, 2026. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.82 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cleopatra Hospital Co's Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was E£1,472 Mil. Therefore, Cleopatra Hospital Co's EV-to-EBIT ratio for today is 19.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cleopatra Hospital Co's Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was E£1,793 Mil. Therefore, Cleopatra Hospital Co's EV-to-EBITDA ratio for today is 15.60.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cleopatra Hospital Co's Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was E£7,581 Mil. Therefore, Cleopatra Hospital Co's EV-to-Revenue ratio for today is 3.69.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Cleopatra Hospital Co's Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was E£1,889 Mil. Therefore, Cleopatra Hospital Co's EV-to-OCF ratio for today is 14.81.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Cleopatra Hospital Co's Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was E£-639 Mil. Therefore, Cleopatra Hospital Co's EV-to-FCF ratio for today is -43.78.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Cleopatra Hospital Co  (CAI:CLHO) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cleopatra Hospital Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=27967.682/1472.282
=19.00

Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil.
Cleopatra Hospital Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£1,472 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cleopatra Hospital Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=27967.682/1792.91
=15.60

Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil.
Cleopatra Hospital Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£1,793 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cleopatra Hospital Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=27967.682/7581.124
=3.69

Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil.
Cleopatra Hospital Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£7,581 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Cleopatra Hospital Co's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=27967.682/1889.002
=14.81

Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil.
Cleopatra Hospital Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£1,889 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Cleopatra Hospital Co's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=27967.682/-638.892
=-43.78

Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil.
Cleopatra Hospital Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-639 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleopatra Hospital Co Enterprise Value Related Terms


Cleopatra Hospital Co Enterprise Value Historical Data

* Premium members only.

The historical data trend for Cleopatra Hospital Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleopatra Hospital Co Enterprise Value Chart

Cleopatra Hospital Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,095.92 8,841.21 7,534.50 13,898.44 22,705.98

Cleopatra Hospital Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,170.28 15,794.35 19,121.14 22,705.98 21,126.28

CAI:CLHO vs HCA, THC, DVA: Enterprise Value Comparison

For the Medical Care Facilities subindustry, Cleopatra Hospital Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleopatra Hospital Co Enterprise Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cleopatra Hospital Co's Enterprise Value falls into.


CAI:CLHO
88GF Score
Cleopatra Hospital Co CAI:CLHO
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleopatra Hospital Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cleopatra Hospital Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Cleopatra Hospital Co's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of E£27,968 Mil mean?
Cleopatra Hospital Co (CAI:CLHO) has a Enterprise Value of E£27,968 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cleopatra Hospital Co and its competitors.
Is Cleopatra Hospital Co's Enterprise Value too high?
Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's Enterprise Value compare to HCA and THC?
Cleopatra Hospital Co's Enterprise Value of E£27,968 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cleopatra Hospital Co and its competitors. Cleopatra Hospital Co's current Enterprise Value is E£27,968 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.82, compared to a current price of E£16.10 — trading 16.5% above its estimated fair value. The current Enterprise Value is E£27,968 Mil. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current Enterprise Value is E£27,968 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£16.10 is trading 16.5% above its estimated GF Value™ of E£13.82. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • Enterprise Value: E£27,968 Mil
  • GF Value™: E£13.82 vs. price of E£16.10 (16.5% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score

Get the complete analysis for CAI:CLHO

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£16.10
Price
E£13.82
GF Value